Zacks Industry Outlook Highlights Exelixis, Blueprint Medicines, CRISPR, Amicus and Verona Pharma

Zacks Oct 25 04:00 ET

Verona Pharma Insider Sold Shares Worth $2,303,773, According to a Recent SEC Filing

MT NewswiresOct 23 03:17 ET

Does Verona Pharma (NASDAQ:VRNA) Have A Healthy Balance Sheet?

Simply Wall StOct 22 09:10 ET

Verona Pharma to Report Third Quarter 2024 Financial Results and Provide Corporate Update

GlobeNewswireOct 21 02:00 ET

Form 144 | Verona Pharma(VRNA.US) Officer Proposes to Sell 3.47 Million in Common Stocks

SEC FILLINGS DISCLOSED/ Oct 18, $Verona Pharma(VRNA.US)$ Officer MARK HAHN intends to sell 100K shares of its common stock on Oct 18, with a total market value of approximately $3.47 million.

Moomoo NewsOct 18 16:25 ET

Form 144 | Verona Pharma(VRNA.US) Director Proposes to Sell 3.47 Million in Common Stocks

SEC FILLINGS DISCLOSED/ Oct 18, $Verona Pharma(VRNA.US)$ Director DAVID ZACCARDELLI intends to sell 100K shares of its common stock on Oct 18, with a total market value of approximately $3.47 million.

Moomoo NewsOct 18 16:25 ET